NANOG and central nervous system cancer: To date, few lncRNAs have been thoroughly described regarding their involvement in stemness, among them H19 (whose downregulation reduces NANOG, OCT4, and SOX2 in glioma and breast cancer63) and lncRNA ROR (which inhibits proliferation of glioma stem cells by negatively regulating KLF464).